[Federal Register Volume 59, Number 22 (Wednesday, February 2, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-2448]


[[Page Unknown]]

[Federal Register: February 2, 1994]


-----------------------------------------------------------------------

Food and Drug Administration
National Institutes of Health

 

Consensus Development Conference on Helicobacter Pylori and 
Peptic Ulcer Disease

    Notice is hereby given to the NIH Consensus Development Conference 
on ``Helicobacter Pylori and Peptic Ulcer Disease,'' which will be held 
February 7-9, 1994, in the Masur Auditorium of the National Institutes 
of Health, 9000 Rockville Pike, Bethesda, Maryland 20892. This 
conference is sponsored by the National Institute of Diabetes and 
Digestive and Kidney Diseases and the NIH Office of Medical 
Applications of Research. The conference is cosponsored by the National 
Institute of Allergy and Infectious Diseases. The conference begins at 
8:30 a.m. on February 7 and 8 and at 9 a.m. on February 9.
    One in a series of NIH Consensus Development Conferences, this 
conference will evaluate all the data that are available on H. pylori 
and its role in causing peptic ulcer disease and gastric malignancy and 
on the best and most appropriate means of diagnosing and treating H. 
pylori infection. The conference will bring together specialists in 
gastroenterology, infectious disease, epidemiology, and pathology, as 
well as representatives from the public.
    Following 1\1/2\ days of presentations and discussion by the 
audience, an independent non-Federal consensus panel will weigh the 
scientific evidence and write a draft statement in response to the 
following key questions:
     What is the role of H. pylori infection in causing peptic 
ulcer disease and gastric malignancy?
     Does eradication of H. pylori infection alter the natural 
history of peptic ulcer disease?
     Which patients with H. pylori infection should be treated?
     What are the best and most appropriate means of diagnosis 
and monitoring of H. pylori infection?
     What are the best means of eradication of H. pylori 
infection?
     What are the most important issues to be addressed by 
future research in H. pylori infection?
    On the final day of the meeting, the consensus panel chairman will 
read the draft statement to the conference audience and invite comments 
and questions.
    Advance information on the conference program and conference 
registration materials may be obtained from: Laura Hazan, Technical 
Resources, Inc., 3202 Tower Oaks Blvd., suite 200, Rockville, Maryland 
20852, (301) 770-3153.
    The final consensus statement will be submitted for publication in 
professional journals and other publications. The final consensus 
statement will be available approximately April 1, 1994. Requests for 
the final consensus statement should be addressed to the NIH Consensus 
Program Information Service, P.O. Box 2577, Kensington, Maryland 20891, 
phone 1-800-NIH-OMAR (1-800-644-6627).

    Dated: January 24, 1994.
Harold Varmus,
Director, NIH.
[FR Doc. 94-2448 Filed 2-1-94; 8:45 am]
BILLING CODE 4140-01-M